Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use? - Quiz - MDSpire

Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?

  • By

  • Margarete Teresa Walach

  • Ralph Burger

  • Felix Brumm

  • Katja Nitschke

  • Frederik Wessels

  • Philipp Nuhn

  • Thomas Stephan Worst

  • Jost von Hardenberg

  • Britta Grüne

  • Jonas Jarczyk

  • January 29, 2025

  • 0 min

Share

Original Source(s)

Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?

  • by Margarete Teresa Walach, Ralph Burger, Felix Brumm, Katja Nitschke, Frederik Wessels, Philipp Nuhn, Thomas Stephan Worst, Jost von Hardenberg, Britta Grüne, Jonas Jarczyk

  • January 29, 2025

Related Content

Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes

Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians

Dana-Farber Cancer Institute’s Dr. Toni Choueiri, Director of the Lank Center for Genitourinary Oncology, was recently elected to one of the nation’s most prestigious medical organizations, The Association of American Physicians (AAP).

  • by

  • April 20, 2026

  • 2 min
Computed tomography guided microwave ablation for the treatment of clinical T1a renal cell carcinoma: a comparison to robot-assisted laparoscopic partial nephrectomy